Lurasidone must be taken with a meal of at least 350 calories to ensure proper absorption (FDA, 2024).
It is one of only a few atypical antipsychotics FDA-approved for pediatric bipolar depression (Ages 10+) (DailyMed, 2023).
Lurasidone has a higher affinity for the 5-HT7 receptor than most other antipsychotics, which may benefit cognitive function (Journal of Psychopharmacology, 2021).
Clinical trials showed a 3-fold increase in peak blood levels when lurasidone was taken with food compared to an empty stomach (FDA Label, 2023).
It carries a Black Box Warning for increased mortality in elderly patients with dementia-related psychosis (FDA, 2024).
Lurasidone is considered to have a lower risk of metabolic side effects, such as weight gain and high cholesterol, than olanzapine (Cochrane Review, 2022).
The elimination half-life of lurasidone is approximately 18 hours, allowing for once-daily dosing (PubChem, 2024).
Grapefruit juice is strictly avoided because it can increase lurasidone levels to toxic amounts (NIH, 2023).
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Latuda, you must consult a qualified healthcare professional.
Lurasidone is a second-generation (atypical) antipsychotic medication primarily used to treat schizophrenia and depressive episodes associated with bipolar I disorder. It modulates dopamine and serotonin receptors to help stabilize mood and improve cognitive function.
💊Usage & Dosage
Adult Dosage
The dosage of lurasidone must be individualized based on the condition being treated and the patient's clinical response. Healthcare providers typically start with a lower dose and gradually increase it (titration) to find the most effective and tolerable amount.
Schizophrenia: The recommended starting dose is 40 mg once daily. Clinical studies indicate that doses ranging from 40 mg to 160 mg per day are effective. The maximum recommended dose for schizophrenia is 160 mg per day.
Bipolar Depression: The recommended starting dose is 20 mg once daily. The dose can be increased up to 120 mg per day if necessary. Interestingly, clinical trials for bipolar depression did not show that higher doses (80-120 mg) were significantly more effective than lower doses (20-60 mg), but some individual patients may require the higher range.
Pediatric Dosage
Lurasidone is approved for use in specific pediatric populations, but strict age limits apply.
Schizophrenia (Ages 13-17): The starting dose is 40 mg once daily, with a target range of 40 mg to 80 mg per day. The maximum dose for adolescents is 80 mg per day.
Bipolar Depression (Ages 10-17): The starting dose is 20 mg once daily. The recommended dose range is 20 mg to 80 mg per day.
Safety Note: Lurasidone has not been studied and is not recommended for children under the age of 10 for bipolar depression or under 13 for schizophrenia.
Dosage Adjustments
Certain medical conditions change how the body processes lurasidone, requiring dosage modifications to prevent toxicity.
Renal Impairment
For patients with moderate to severe renal (kidney) impairment (creatinine clearance < 50 mL/min), the starting dose should not exceed 20 mg, and the maximum dose should be capped at 80 mg per day. No adjustment is typically needed for mild renal impairment.
Hepatic Impairment
For patients with moderate hepatic (liver) impairment (Child-Pugh Score 7 to 9), the starting dose is 20 mg with a maximum of 80 mg. For those with severe hepatic impairment (Child-Pugh Score 10 to 15), the maximum dose is restricted to 40 mg per day.
Elderly Patients
While no specific dose adjustment is universally required for the elderly based solely on age, healthcare providers often start at the lower end of the dosing range due to the higher frequency of decreased hepatic, renal, or cardiac function in this population.
How to Take Lurasidone
To ensure the medication is absorbed correctly and works as intended, patients must follow these specific administration rules:
1The 350-Calorie Rule: Lurasidone must be taken with food. A meal or snack containing at least 350 calories is required. If taken on an empty stomach, the medication will not be absorbed properly, and it may not be effective. The type of food (fat vs. protein) is less important than the total calorie count.
2Consistency: Take the medication at the same time every day to maintain steady levels in your bloodstream.
3Swallow Whole: Tablets should be swallowed whole. Do not crush, chew, or break the tablets unless specifically instructed by your doctor, as this can affect how the drug is released.
4Storage: Store the medication at room temperature (68°F to 77°F) in a dry place away from moisture and light.
Missed Dose
If you miss a dose of lurasidone, take it as soon as you remember, provided you can take it with the required 350 calories of food. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Never 'double up' on doses to make up for a missed one, as this increases the risk of serious side effects.
Overdose
Signs of a lurasidone overdose may include extreme drowsiness, rapid heartbeat (tachycardia), seizures, or uncontrollable muscle movements. Because lurasidone is highly protein-bound, dialysis is not effective in removing it from the system. In the event of a suspected overdose, contact your local poison control center or seek emergency medical attention immediately. Provide the medical team with the exact time of ingestion and the estimated amount taken.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop taking the medication without medical guidance, as sudden discontinuation can lead to a return of psychiatric symptoms.
⚠️Side Effects
Common Side Effects (>1 in 10)
Most patients taking lurasidone will experience at least one mild to moderate side effect. These often occur during the first few weeks of treatment as the body adjusts to the medication.
Somnolence (Drowsiness): This is one of the most frequently reported side effects. It can range from mild tiredness to a heavy feeling of sedation. Taking the medication at night may help manage this.
Akathisia: This is a specific type of movement disorder characterized by an inner sense of restlessness and an urgent need to move. Patients often describe it as 'feeling like I'm jumping out of my skin' or being unable to sit still.
Nausea: Feeling sick to the stomach is common, especially when starting the medication. Because lurasidone must be taken with food, the meal itself may help mitigate some of the nausea.
Extrapyramidal Symptoms (EPS): This refers to various movement issues, including muscle stiffness, tremors, or slow movements (bradykinesia).
🔴Warnings
Important Safety Information
Lurasidone is a powerful psychiatric medication that requires careful medical supervision. It is essential that patients understand that this medication does not cure schizophrenia or bipolar disorder; rather, it helps manage the symptoms. Treatment should never be stopped abruptly, as this can lead to a rapid return of symptoms or withdrawal-like effects.
Black Box Warnings
The FDA has mandated the following Black Box Warnings for lurasidone:
Dementia-Related Psychosis: There is an increased risk of death in elderly patients with dementia who take antipsychotics. Most deaths appear to be cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia) in nature.
Suicidality: In clinical trials of patients with bipolar depression, there was an observed increase in suicidal thinking and behavior in pediatric and young adult patients. Families and caregivers should be alert to daily changes in mood, behavior, or signs of agitation.
🔄Interactions
Contraindicated Combinations (Do Not Use Together)
Lurasidone is primarily broken down by the CYP3A4 enzyme in the liver. Therefore, any drug that strongly interferes with this enzyme will cause dangerous changes in lurasidone levels.
Strong CYP3A4 Inhibitors: Drugs like ketoconazole, clarithromycin, and ritonavir can increase lurasidone levels by several hundred percent, leading to severe toxicity. Using these together is strictly contraindicated.
Strong CYP3A4 Inducers: Drugs like rifampin, carbamazepine, and phenytoin can speed up the breakdown of lurasidone so much that it becomes completely ineffective. These combinations must be avoided.
Serious Interactions (Monitor Closely)
Moderate CYP3A4 Inhibitors: Examples include diltiazem, erythromycin, and verapamil. If these must be used, the dose of lurasidone should be reduced (typically to a maximum of 80 mg).
🚫Contraindications
Absolute Contraindications
There are specific circumstances where lurasidone must never be used due to the high risk of life-threatening complications.
1Known Hypersensitivity: If a patient has had a previous severe allergic reaction to lurasidone hydrochloride or any of the inactive ingredients in the tablet (such as angioedema or severe rash), the drug is strictly contraindicated.
2Strong CYP3A4 Inhibitors: Lurasidone must not be used in combination with strong inhibitors of the CYP3A4 enzyme (e.g., ketoconazole, clarithromycin, ritonavir). The mechanism is the inhibition of lurasidone's primary metabolic pathway, which can lead to a 6-fold to 9-fold increase in drug exposure, causing severe toxicity.
3Strong CYP3A4 Inducers: Lurasidone must not be used with strong inducers of the CYP3A4 enzyme (e.g., rifampin, St. John's Wort, phenytoin). These substances cause the body to clear lurasidone so quickly that therapeutic levels cannot be maintained, rendering the treatment useless.
👥Special Populations
Pregnancy
Lurasidone is classified by the FDA as a Pregnancy Category B medication (based on the older system), meaning animal studies have not shown a risk to the fetus, but there are no adequate and well-controlled studies in pregnant women.
Trimester-Specific Risks: During the third trimester, exposure to antipsychotic medications like lurasidone increases the risk of extrapyramidal symptoms (movement disorders) and withdrawal symptoms in the newborn after delivery. These symptoms can include agitation, hypertonia (increased muscle tone), hypotonia (decreased muscle tone), tremor, somnolence, and respiratory distress.
Clinical Decision: Lurasidone should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Stopping the medication during pregnancy can lead to a relapse of schizophrenia or bipolar depression, which also carries significant risks for both the mother and the baby.
Breastfeeding
It is not known whether lurasidone is excreted in human breast milk. However, animal studies have shown that lurasidone is present in the milk of lactating rats. Because of the potential for serious adverse reactions in nursing infants (such as sedation or movement issues), a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
🧬Pharmacology
Mechanism of Action
Lurasidone is an atypical antipsychotic with a unique binding profile. Its primary therapeutic effects are mediated through a combination of central dopamine D2 and serotonin 5-HT2A receptor antagonism.
D2 Antagonism: By blocking dopamine D2 receptors in the mesolimbic pathway, lurasidone reduces the 'positive' symptoms of schizophrenia.
5-HT2A Antagonism: Blocking these serotonin receptors helps modulate dopamine release in other areas of the brain, potentially improving mood and reducing movement side effects.
5-HT7 Antagonism: Lurasidone has a very high affinity (Ki = 0.5 nM) for the 5-HT7 receptor. This is thought to contribute to its pro-cognitive and antidepressant effects.
5-HT1A Partial Agonism: Acts as a partial agonist (Ki = 6.4 nM) at this receptor, which may help alleviate anxiety and depressive symptoms.
Frequently Asked Questions
Common questions about Latuda
What is Lurasidone used for?
Lurasidone is primarily used to treat schizophrenia in adults and adolescents aged 13 and older. It is also FDA-approved for the treatment of depressive episodes associated with Bipolar I Disorder (bipolar depression) in adults and children aged 10 and older. In bipolar depression, it can be used alone or in combination with other mood stabilizers like lithium or valproate. Healthcare providers choose lurasidone for these conditions because it helps balance brain chemicals like dopamine and serotonin. It is not approved for treating psychosis related to dementia in elderly patients.
What are the most common side effects of Lurasidone?
The most common side effects reported by patients include sleepiness or drowsiness (somnolence), a feeling of restlessness or the need to move (akathisia), and nausea. Some people may also experience muscle stiffness, tremors, or slow movements, which are known as extrapyramidal symptoms. Because the medication can cause drowsiness, it is often recommended to take it in the evening. Most of these side effects are mild to moderate and may decrease as your body gets used to the medication. Always report persistent or worsening side effects to your doctor.
Can I drink alcohol while taking Lurasidone?
It is strongly recommended that you avoid drinking alcohol while taking lurasidone. Alcohol is a central nervous system depressant, and when combined with lurasidone, it can significantly increase drowsiness and impair your coordination and judgment. This combination can also increase the risk of respiratory depression, making it harder to breathe. Furthermore, alcohol can interfere with the management of the underlying psychiatric condition lurasidone is treating. Discuss your alcohol consumption habits with your healthcare provider before starting this medication.
Is Lurasidone safe during pregnancy?
The safety of lurasidone during pregnancy is not fully established, as there are no comprehensive studies in pregnant women. Animal studies have not shown direct harm to the fetus, but babies born to mothers who took antipsychotics during the third trimester may experience withdrawal symptoms or movement disorders after birth. These symptoms can include agitation, tremors, or breathing difficulties. If you become pregnant while taking lurasidone, do not stop the medication suddenly, as this could cause a relapse of your condition. Instead, contact your doctor immediately to discuss the risks and benefits of continuing treatment.
How long does it take for Lurasidone to work?
While some patients may notice a slight improvement in their symptoms within the first 1 to 2 weeks of treatment, it typically takes longer to see the full benefits. For schizophrenia and bipolar depression, it may take 4 to 6 weeks of consistent use to achieve the maximum therapeutic effect. It is important to continue taking the medication exactly as prescribed, even if you do not feel better right away. If you feel the medication is not working after several weeks, consult your doctor rather than adjusting the dose yourself. Consistent dosing with at least 350 calories of food is required for the drug to work effectively.
Can I stop taking Lurasidone suddenly?
No, you should never stop taking lurasidone suddenly without consulting your healthcare provider. Abruptly discontinuing an antipsychotic can lead to a 'rebound' effect, where psychiatric symptoms like hallucinations or severe depression return quickly and sometimes more intensely. It can also cause physical withdrawal symptoms such as nausea, sweating, and insomnia. If you and your doctor decide to stop the medication, they will provide a tapering schedule to gradually reduce the dose. This allows your brain chemistry to adjust slowly and safely.
What should I do if I miss a dose of Lurasidone?
If you miss a dose of lurasidone, take it as soon as you remember, but only if you can take it with at least 350 calories of food. If it is nearly time for your next scheduled dose, skip the missed dose and take your next one at the usual time. Do not take two doses at once to make up for the missed one, as this significantly increases the risk of side effects like extreme drowsiness or movement disorders. Consistency is key to the effectiveness of lurasidone, so try to take it at the same time every day. If you frequently miss doses, talk to your doctor about strategies to help you remember.
Does Lurasidone cause weight gain?
Lurasidone is generally considered to be 'weight-neutral' compared to many other atypical antipsychotics, meaning it has a lower risk of causing significant weight gain. In clinical trials, the average weight gain was minimal for most patients. However, weight gain is still a possible side effect, and some individuals may be more affected than others. Your healthcare provider will monitor your weight and body mass index (BMI) regularly while you are taking this medication. Maintaining a healthy diet and regular exercise routine can help manage any potential weight changes.
Can Lurasidone be taken with other medications?
Lurasidone can interact with many other medications, particularly those that affect the CYP3A4 liver enzyme. Strong inhibitors (like certain antifungals or HIV meds) and strong inducers (like certain seizure meds or St. John's Wort) must be avoided entirely. Other medications that cause drowsiness, such as opioids or benzodiazepines, can increase the sedative effects of lurasidone. Always provide your doctor and pharmacist with a complete list of all prescription drugs, over-the-counter medicines, and herbal supplements you are taking. This allows them to check for potentially dangerous interactions before you start lurasidone.
Is Lurasidone available as a generic?
Yes, lurasidone hydrochloride is available as a generic medication. The generic version became widely available in the United States in early 2023 following the expiration of the patent for the brand-name drug, Latuda. Generic medications are required by the FDA to have the same active ingredient, strength, dosage form, and route of administration as the brand-name product. Choosing the generic version can significantly reduce the cost of treatment for many patients. Check with your pharmacist or insurance provider to see if the generic version is covered under your plan.
Similar Medications
Other drugs with the same active ingredient (Lurasidone)
Insomnia: Some patients may find it difficult to fall or stay asleep.
Vomiting: More severe than simple nausea, this may require a dose adjustment.
Increased Salivation: A noticeable increase in saliva production or drooling.
Dystonia: Sudden, involuntary muscle contractions, often in the neck, jaw, or tongue.
Weight Gain: While lurasidone is considered 'weight-neutral' compared to other antipsychotics, some patients may still experience a modest increase in weight.
Rare Side Effects (less than 1 in 100)
Hyperprolactinemia: An increase in the hormone prolactin, which can lead to breast swelling, nipple discharge, or changes in menstrual periods.
Dyslipidemia: Changes in cholesterol or triglyceride levels.
Tardive Dyskinesia (TD): A potentially irreversible condition involving repetitive, involuntary movements, typically of the face, tongue, or jaw. The risk of TD increases with the duration of treatment and the cumulative dose.
Serious Side Effects — Seek Immediate Medical Attention
> Warning: Stop taking Lurasidone and call your doctor immediately if you experience any of these serious reactions.
Neuroleptic Malignant Syndrome (NMS): A rare but life-threatening reaction characterized by high fever, stiff muscles, confusion, sweating, and changes in heart rate or blood pressure. This is a medical emergency.
Severe Allergic Reactions: Symptoms include rash, itching, hives, and swelling of the face, lips, or throat (angioedema).
Seizures: Lurasidone can lower the seizure threshold, especially in patients with a history of epilepsy.
High Blood Sugar (Hyperglycemia): In extreme cases, this can lead to ketoacidosis or coma. Symptoms include extreme thirst, frequent urination, and fruity-smelling breath.
Low White Blood Cell Count: A significant drop in infection-fighting cells (leukopenia or neutropenia) can occur, making you more susceptible to infections.
Long-Term Side Effects
With prolonged use, patients should be monitored for metabolic changes. Although lurasidone has a lower risk than some other medications, long-term use can still contribute to the development of Type 2 Diabetes or cardiovascular issues. Regular monitoring of weight, blood glucose, and lipid profiles is recommended. Additionally, the risk of Tardive Dyskinesia is a primary concern with long-term antipsychotic therapy; healthcare providers should perform regular 'AIMS' (Abnormal Involuntary Movement Scale) exams to catch early signs of this condition.
Black Box Warnings
Lurasidone carries two critical FDA Black Box Warnings—the most serious type of warning issued by the FDA.
1Increased Mortality in Elderly Patients with Dementia-Related Psychosis: Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Lurasidone is not approved for the treatment of patients with dementia-related psychosis.
2Suicidal Thoughts and Behaviors: Antidepressants and some antipsychotics used for depression can increase the risk of suicidal thoughts and behaviors in children, adolescents, and young adults (up to age 24). Patients of all ages starting lurasidone for bipolar depression should be monitored closely for worsening of symptoms or the emergence of suicidal ideation.
Report any unusual symptoms or changes in mood to your healthcare provider immediately.
Major Precautions
Cerebrovascular Adverse Reactions: In clinical trials of elderly patients with dementia, there was a higher incidence of stroke and transient ischemic attacks (TIAs) in those taking antipsychotics.
Neuroleptic Malignant Syndrome (NMS): This is a potentially fatal symptom complex. If a patient develops high fever and muscle rigidity, the medication must be discontinued immediately.
Tardive Dyskinesia: The risk of developing involuntary movements increases with the length of treatment. If signs of TD appear, the healthcare provider may consider stopping the medication.
Metabolic Changes: Atypical antipsychotics are associated with metabolic changes, including high blood sugar (hyperglycemia), high cholesterol (dyslipidemia), and weight gain. Regular blood tests are required.
Orthostatic Hypotension and Syncope: Lurasidone may cause a sudden drop in blood pressure when standing up, which can lead to dizziness or fainting. This is most common when first starting the drug or increasing the dose.
Hyperprolactinemia: Like other D2 antagonists, lurasidone can elevate prolactin levels, which may affect reproductive function and bone density over time.
Monitoring Requirements
To ensure safety, your healthcare provider will likely require the following tests:
Blood Glucose: To monitor for the development of diabetes.
Lipid Panel: To check cholesterol and triglyceride levels.
Weight/BMI: Monitored at every visit.
CBC (Complete Blood Count): To ensure white blood cell counts remain within a safe range.
AIMS Exam: A physical assessment for involuntary movements.
Driving and Operating Machinery
Lurasidone can cause significant somnolence (drowsiness) and may impair judgment, thinking, and motor skills. Patients should not drive, operate heavy machinery, or engage in dangerous activities until they are certain the medication does not affect them in these ways.
Alcohol Use
Alcohol should be avoided while taking lurasidone. Alcohol can worsen the sedative effects of the medication and increase the risk of respiratory depression and impaired motor coordination.
Discontinuation
If you and your doctor decide to stop lurasidone, the dose should be tapered (gradually reduced) rather than stopped suddenly. Abruptly stopping can cause 'rebound' psychosis or symptoms like nausea, sweating, and insomnia.
> Important: Discuss all your medical conditions, especially heart problems, diabetes, or a history of seizures, with your healthcare provider before starting Lurasidone.
Moderate CYP3A4 Inducers: Drugs like modafinil or bosentan may decrease lurasidone levels, requiring a potential dose increase of lurasidone.
CNS Depressants: Taking lurasidone with other drugs that cause drowsiness—such as benzodiazepines (e.g., lorazepam), opioids, or certain sleep medications—can lead to extreme sedation and respiratory issues.
Moderate Interactions
Antihypertensive Agents: Because lurasidone can cause orthostatic hypotension (dizziness upon standing), taking it with blood pressure medications may increase the risk of fainting and falls.
Dopamine Agonists: Drugs used for Parkinson’s disease (like levodopa) work by increasing dopamine, while lurasidone works by blocking it. These drugs can cancel each other out, worsening both conditions.
Food Interactions
Grapefruit and Grapefruit Juice: Grapefruit is a potent inhibitor of the CYP3A4 enzyme. Consuming grapefruit while taking lurasidone can lead to dangerously high levels of the drug in your system. It is best to avoid grapefruit products entirely.
High-Calorie Requirement: As noted previously, lurasidone requires at least 350 calories for absorption. Failure to meet this requirement is a 'negative interaction' that results in sub-therapeutic drug levels.
Herbal/Supplement Interactions
St. John’s Wort: This herbal supplement is a strong inducer of CYP3A4. Taking it with lurasidone can significantly reduce the medication's effectiveness, potentially leading to a relapse of psychiatric symptoms.
Kava, Valerian, and Melatonin: These supplements have sedative properties and may increase the drowsiness caused by lurasidone.
Lab Test Interactions
Lurasidone does not typically interfere with common laboratory tests, but it can cause physiological changes that show up on labs, such as:
False Positives for Urine Drug Screens: Some antipsychotics have been known to cause false positives for methadone or amphetamines, though this is less common with lurasidone than with other agents.
Prolactin Elevation: Can be seen on hormone blood tests.
For each major interaction, the mechanism usually involves the liver's metabolic pathways. When lurasidone levels are too high, the clinical consequence is an increased risk of movement disorders and sedation. When levels are too low, the consequence is a lack of symptom control. Management strategies always involve dose titration or choosing alternative medications under strict medical supervision.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter cold medicines or vitamins.
Relative Contraindications
These are conditions where the drug should be used only if the benefits clearly outweigh the risks, and with extreme caution.
Elderly Patients with Dementia: Due to the increased risk of death and stroke, lurasidone is generally avoided in this population unless no other options exist and the psychiatric symptoms are severe.
Severe Hepatic or Renal Impairment: While not an absolute contraindication, these conditions require significant dose reductions and frequent monitoring.
History of Seizures: Lurasidone can lower the threshold for seizures. It should be used cautiously in patients with epilepsy or conditions that predispose them to seizures (e.g., head trauma).
Cardiovascular Disease: Patients with a history of heart attack, heart failure, or conduction abnormalities (like QT prolongation) require careful monitoring because lurasidone can cause orthostatic hypotension.
Cross-Sensitivity
While lurasidone is chemically distinct, patients who have had severe reactions to other benzoisothiazol derivatives (such as ziprasidone) should be monitored closely, as there is a theoretical risk of cross-sensitivity, though this is not well-documented in clinical literature.
> Important: Your healthcare provider will evaluate your complete medical history, including any past reactions to psychiatric medications, before prescribing Lurasidone.
Pediatric Use
Lurasidone is FDA-approved for:
Schizophrenia: Children aged 13 to 17 years.
Bipolar Depression: Children aged 10 to 17 years.
The safety and effectiveness of lurasidone in children under 10 years of age have not been established. In pediatric trials, the side effect profile was generally similar to that seen in adults, though there was a slightly higher incidence of weight gain and somnolence in younger patients.
Geriatric Use
Clinical studies of lurasidone did not include sufficient numbers of patients aged 65 and over to determine if they respond differently than younger patients. However, geriatric patients are generally more sensitive to the side effects of antipsychotics, particularly:
Fall Risk: Due to sedation and orthostatic hypotension.
Tardive Dyskinesia: Elderly women are at the highest risk for this movement disorder.
Renal Clearance: Many elderly patients have reduced kidney function, which necessitates lower starting doses.
Renal Impairment
In patients with moderate (CrCl 30-50 mL/min) and severe (CrCl < 30 mL/min) renal impairment, the body's ability to clear lurasidone is reduced.
Dose Adjustment: The starting dose should be 20 mg, and the dose should not exceed 80 mg per day. Lurasidone has not been extensively studied in patients on hemodialysis.
Hepatic Impairment
Moderate Impairment (Child-Pugh 7-9): The dose should be capped at 80 mg.
Severe Impairment (Child-Pugh 10-15): The dose should be capped at 40 mg.
Mechanism: Since the liver is the primary site of metabolism, impairment leads to higher blood levels of the drug, increasing the risk of adverse effects.
> Important: Special populations require individualized medical assessment and frequent follow-up to ensure the medication remains safe and effective over time.
Minimal Off-Target Binding: It has low affinity for alpha-1 adrenergic receptors and almost no affinity for histamine H1 or muscarinic M1 receptors, explaining its lower incidence of weight gain and dry mouth.
Pharmacodynamics
The onset of action for lurasidone typically occurs within 1 to 2 weeks for initial symptom improvement, though the full therapeutic effect may take 4 to 6 weeks. It does not appear to cause significant QT prolongation (a heart rhythm issue) at therapeutic doses, which is a safety advantage over some other antipsychotics like ziprasidone.
Solubility: Very slightly soluble in water; soluble in methanol.
Structure: It is a benzoisothiazol derivative characterized by a piperazine-based side chain and a bicyclic ring system.
Drug Class
Lurasidone is classified as an atypical (second-generation) antipsychotic. It is related to other medications in this class, such as aripiprazole, quetiapine, and risperidone, but is distinguished by its specific 5-HT7 receptor affinity and its metabolic-friendly profile.